The Effect of Probiotics in Stroke Treatment

Table 1

Basic information on the included literature.

Study	Disease	Course of treatment	Treatment group			Control group
			Treatment	Male/female	Age	Treatment	Male/female	Age
Bai et al. [11]	IS + HS	1 w	PLBP + ENS	—	—	ENS	—	—
Ban et al. [12]	IS + HS	14 w	BLTLBT + ENS	25/10	65.8 ± 10.5	ENS	26/9	66.5 ± 8.3
Chen [13]	IS + HS	14d	BLTLBT + F	—	—	F	—	—
Chen et al. [14]	IS	14 d	PLBP + S	23/12	70.69 ± 11.68	S	19/15	71.37 ± 12.56
Dong [15]	IS + HS	14 d	PLBP + ENS	—	—	ENS	—	—
Feng [16]	IS	14 d	PLBP + FD	27/13	58.55 ± 8.67	FD	25/15	54.78 ± 7.74
Gao [17]	IS + HS	2 w	PLBP + ENS	21/19	58.2 ± 2.1	ENS	15/25	51.1 ± 2.3
Geng et al. [18]	IS	15 d	PP + ENS	33/24	65.8 ± 2.7	ENS	30/27	66.4 ± 22.4
He et al. [19, 20]	IS	1 m	PLBP + ENS	36/24	70.97 ± 10.86	ENS	16/14	69.21 ± 1 2.08
Huang and Yuan [20]	IS	21 d	BLTLBT + ENS	16/19	54.98 ± 5.10	ENS	15/20	55.21 ± 5.12
Jin [21]	IS	4 w	BTVEC + ENS	—	—	ENS	—	—
Jin et al. [22]	IS + HS	7–14 d	BLTLBT + ENS	13/15	62.18 ± 11.12	ENS	17/11	62.07 ± 10.94
Liang et al. [23]	HS	60 d	PLBP + FD	—	60.19 ± 18.65	FD	—	62.13 ± 13.97
Li et al. [24]	IS + HS	2 w	BQVT + ENS	29/11	—	ENS	28/12	—
Li [25]	HS	21 d	LCC + F	13/10	60.9 ± 8.7	F	14/8	59.5 ± 8.9
Li et al. [26]	HS	2 w	BLTLBT + ENE	24/19	60.90 ± 8.60	ENE	27/16	61.66 ± 10.64
Ma [27]	HS	20 d	BQVT + ENS	25/22	52 ± 6	ENS	26/20	52 ± 6
Pei [28]	IS + HS	4 w	PLBP + ENS	32/28	64 ± 10	ENS	35/25	62 ± 11
Yang [29]	IS + HS	7 w	PLBP + ENS	15/15	59.89 ± 3.46	ENS	17/13	60.23 ± 4.56
Yuan [30]	HS	2 w	BTVEC + HP	28/12	58.4 ± 9.3	HP	27/13	59.1 ± 8.8
Zhang [31]	IS	14 d	PLBP + EP	30/40	64.21 ± 9.27	EP	32/38	63.49 ± 10.64
Zhang et al. [32]	HS	21 d	LCC + F	13/10	60.9 ± 8.7	F	14/8	59.5 ± 8.9
Zhang [33]	IS + HS	8 w	LCBC	—	—	—	—	—

IS: ischemic stroke; HS: hemorrhagic stroke; m: month; w: week; d: day; PLBP: probiotic live bacteria preparation; BLTLBT: bifidobacterium lactobacillus triple live bacteria tablets; BTVEC: bifidobacterium triple viable enteric-coated capsules; PP: probiotic pellets; BQVT: bifidobacterium quadruple viable tablets; LCC: Livzon Changle capsules; LCBC: live clostridium butyricum capsules; EN: enteral nutrients; ST: life support treatment; F: fresubin; S: supportan; FD: fresubin diabetic; EP: ensure powder; HP: homogenate preparation; ENS: enteral nutrient solution or suspension; ENE: enteral nutrient emulsion.